Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Curr Med Chem ; 21(25): 2864-80, 2014.
Article in English | MEDLINE | ID: mdl-24606515

ABSTRACT

Epidemiological studies have shown that low plasma levels of High Density Lipoprotein Cholesterol (HDL-C) are associated with an increased risk for myocardial infarction. These studies suggested that by increasing HDL-C levels one could reduce cardiovascular risk. However, emerging evidence from studies in animals and humans indicate that high levels of HDL-C are not sufficient to confer atheroprotection but that the functionality of the HDL particles is equally important. The picture is complicated further by the finding that HDL functionality is compromised in patients with chronic inflammatory diseases such as Coronary Artery Disease (CAD), diabetes and rheumatoid arthritis. Despite these obstacles, HDL raising is still a promising strategy for the reduction of CAD risk. Low HDL-C can be caused by inactivating mutations in apoA-I, ATP Binding Cassette Transporter A1 (ABCA1) or Lecithin-Cholesterol Acyl Transferase (LCAT) which affect HDL biogenesis and maturation whereas high HDL-C can be caused by mutations in Cholesteryl Ester Transfer Protein (CETP) or Scavenger receptor Class B Type I (SR-BI). Recent studies suggest that heterogeneity in HDL levels in the population is polygenic in origin. One approach to raise plasma HDL-C is to increase the rate of HDL biosynthesis by capitalizing on the mechanisms that control the transcription of genes that play key roles in HDL biogenesis. We review some of the genetic and non-genetic factors that affect plasma HDL levels and functions and discuss the mechanisms that regulate HDL metabolism at the level of gene transcription in the liver focusing on apoA-I, ABCA1 and apoM.


Subject(s)
Lipoproteins, HDL/metabolism , Animals , Apolipoprotein A-I/genetics , Apolipoprotein A-I/metabolism , Gene Expression Regulation , Genetic Heterogeneity , Humans , Protein Multimerization , Transcription, Genetic
2.
Neurol Med Chir (Tokyo) ; 38(10): 666-8, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9861852

ABSTRACT

A 36-year-old female presented with cerebral infarction due to severe vessel stenosis after spontaneous rupture of a craniopharyngioma, manifesting as aphasia and drowsiness. Neuroimaging showed the suprasellar cystic tumor with wall enhancement and cerebral infarction in the left temporoparietal region, and also enhancement of the left sylvian fissure and prepontine cistern. Angiography showed severe narrowing at the C1 portion of the left internal carotid artery (ICA) and the M1 portion of the left middle cerebral artery (MCA). The tumor was subtotally removed via a bifrontal craniotomy. There was accumulated milky-white debris around the left ICA and MCA. She became alert within a few days postoperatively. Repeat angiography 1 month after surgery demonstrated slight improvement of vessel narrowing. The neuroimaging and intraoperative findings suggested that the stenosis was due to vasospasm induced by chemical meningitis resulting from cyst rupture.


Subject(s)
Carotid Arteries/diagnostic imaging , Carotid Arteries/pathology , Craniopharyngioma/diagnosis , Cysts/diagnosis , Pituitary Neoplasms/diagnosis , Adult , Cerebral Angiography , Cerebral Infarction/diagnosis , Cerebral Infarction/etiology , Craniopharyngioma/complications , Craniopharyngioma/surgery , Cysts/surgery , Female , Humans , Magnetic Resonance Imaging , Pituitary Neoplasms/complications , Pituitary Neoplasms/surgery , Rupture, Spontaneous , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...